A Phase I Study of Ruxolitinib in Combination with Abemaciclib for Patients with Primary or Post-Polycythemia Vera/Essential Thrombocythemia Myelofibrosis

被引：0

作者：

Bewersdorf, Jan Philipp ^{[1
]}

Derkach, Andriy ^{[2
]}

Masarova, Lucia ^{[3
]}

Pemmaraju, Naveen ^{[3
]}

Stein, Eytan M. ^{[4
]}

Mauro, Michael ^{[1
]}

Rampal, Raajit K. ^{[1
]}

Bose, Prithviraj ^{[5
]}

机构：

[1] Mem Sloan Kettering Canc Ctr, New York, NY USA

[2] Mem Sloan Kettering Canc Ctr, Dept Biostat & Epidemiol, New York, NY USA

[3] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA

[4] Mem Sloan Kettering Canc Ctr, Leukemia Serv, New York, NY USA

[5] MD Anderson Canc Ctr, Houston, TX USA

来源：

关键词：

D O I：

10.1182/blood-2023-174322

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：5